Overview
| Name | Borzoi · aliases: Borzoi |
|---|---|
| Full name | No separate expanded name |
| Ambiguous names (not auto-linked) | Flashzoi, Borzoi Prime |
| Family | Not a family entry. Single-model entry, not a family |
| Organization | Calico Life Sciences |
| Organization type | Big-tech lab |
| Country | United States |
| Model class | Sequence-to-function model |
| Domain | Genomics & RNA |
| First release | · preprint Basis: bioRxiv v1 posted (Crossref issued the same day) source |
| Other milestones | |
| Latest update | · journal Basis: Nature Genetics publication Published in Nature Genetics; later commits to 2026-09-30 are CI and dependency maintenance only source The most recent sourced event, not a claim that nothing changed since. |
| Status | Maintained only · Only maintenance commits after publication |
| Openness | Code: Open · Apache-2.0 Weights: Open Open source; code under Apache-2.0 |
| Benchmarks reported | 2 counted (self 1, retrospective 1) |
| Wet-lab validation | None recorded |
| Unverified fields | None |
| As of | 2026-11-16 |
What it does
Predicts RNA-seq coverage directly from DNA sequence and uses it to score variant effects on transcription, splicing and polyadenylation; continues the Basenji/Enformer line and is in the same class as AlphaGenome.
Benchmarks reported
Every row is one pairing from the survey's relation file; a score belongs to the benchmark page's ranking, where it is shown with metric, eval set, source type and date. 2 of 2 pairings are counted.
| Benchmark | Relation | Eval set / protocol | Source type | Note and evidence |
|---|---|---|---|---|
| 08 Basenji/Enformer test set | Developer report, official protocol | — | Self-reported | The paper uses its own variant tasks and also reports on this test set · evidence |
| 37 TraitGym | Retrospective dataset use | — | Third-party | Evaluated on this set by the benchmark's authors. †partly verified · evidence |
Other evaluations (outside the 44)
None recorded.
Developers report: Source states no developer claim
Independent evidence: TraitGym authors find it stronger on complex non-disease traits but behind alignment-based models on Mendelian and disease traits
Training data
Group in Figure 7: Public data only.
| Class | Value | Detail |
|---|---|---|
| a. Public databases | Yes | ENCODE RNA-seq, GTEx v8, FANTOM5 CAGE, DNase, ChIP-seq etc.; 7,611 human output tracks |
| b. Private or licensed data | No | |
| c. Own wet-lab data used for training | No | |
| d. Wet lab used only for validation | No |
Wet-lab validation
None. The developers report no wet-lab validation.
Background
- Organization: Calico is an Alphabet aging-biology company announced 2013-09; Basenji and Borzoi come from its team
- Funding: Not disclosed or not applicable
- Products and partnerships: The AbbVie partnership in place since 2014 reportedly ended in 2025-11 (press report)
- Related models: AlphaGenome, NTv3
Reading notes
- Enformer test-set comparisons were run by the developers
- TraitGym results show clear differences across trait classes
Caveats
- bioRxiv posting day 2023-08-31 vs 09-01 is uncertain; API record gives 09-01
- Borzoi Prime and Flashzoi not verified and not merged here
Sources
- Crossref record 10.1038/s41588-024-02053-6 (journal)
- bioRxiv preprint (preprint)
- GitHub repository calico/borzoi (repository)
- Journal article DOI 10.1038/s41588-024-02053-6 (journal)
- bioRxiv preprint (preprint)
Corrections
1 correction
| Field | Was | Now | Basis | Found |
|---|---|---|---|---|
| first_release | 2023-08-31 | 2023-09-01 (bioRxiv v1 and Crossref issued date) | source | 2026-11-16 |
Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-16.